The article did not go unnoticed. One predatory drug company, Purdue Pharma, apparently liked McKinsey’s ideas. From 2004 to 2019, Purdue paid McKinsey $83.7 million in fees for marketing advice that made its billionaire owners even richer by stoking the nation’s appetite for the painkilling drug OxyContin.
